Kun Zhang
Director/Board Member at SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED
Net worth: 3 M $ as of 31/05/2024
Kun Zhang active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Director/Board Member | 20/04/2018 | - |
| Corporate Officer/Principal | 20/04/2018 | - |
Career history of Kun Zhang
Former positions of Kun Zhang
| Companies | Position | Start | End |
|---|---|---|---|
Essen Technology (Beijing) Co., Ltd.
 Essen Technology (Beijing) Co., Ltd. Medical SpecialtiesHealth Technology Essen Technology (Beijing) Co., Ltd. engages in the research and development, production, and sale of medical devices. It offers Tivoli drug-eluting coronary stents. The company was founded on August 10, 2006 and is headquartered in Beijing, China. | Corporate Officer/Principal | 01/11/2014 | 01/10/2020 |
| SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Sales & Marketing | 01/05/2009 | 01/01/2011 |
| MICROPORT SCIENTIFIC CORPORATION | Sales & Marketing | 01/05/2002 | 01/03/2004 |
Training of Kun Zhang
| City University of Hong Kong | Masters Business Admin |
| Academy of Armored Forces Engineering | Undergraduate Degree |
Statistics
International
| China | 6 |
| Hong Kong | 2 |
Operational
| Sales & Marketing | 2 |
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| MICROPORT SCIENTIFIC CORPORATION | Health Technology |
| SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Commercial Services |
| SHANGHAI HEARTCARE MEDICAL TECHNOLOGY CORPORATION LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
Essen Technology (Beijing) Co., Ltd.
Essen Technology (Beijing) Co., Ltd. Medical SpecialtiesHealth Technology Essen Technology (Beijing) Co., Ltd. engages in the research and development, production, and sale of medical devices. It offers Tivoli drug-eluting coronary stents. The company was founded on August 10, 2006 and is headquartered in Beijing, China. | Health Technology |
- Stock Market
- Insiders
- Kun Zhang
- Experience
